Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,577,448
+$926,969 QoQ
Shares Held
29,836
+9.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,292
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $24,225,985 across 10 Drug Manufacturers - General names. JNJ ranks #1 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
29,836 | $7,577,448 | |
| 2 | ABBV |
AbbVie Inc.
|
20,373 | $5,126,661 | |
| 3 | LLY |
ELI LILLY & Co
|
4,139 | $4,964,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,514 | $3,407,049 | |
| 5 | PFE |
Pfizer Inc
|
31,586 | $760,590 | |
| 6 | AMGN |
Amgen Inc
|
1,749 | $633,347 | |
| 7 | NVS |
Novartis AG
|
3,412 | $534,728 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,910 | $493,989 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,577,448 | 29,836 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,650,479 | 27,207 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,767,903 | 27,871 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,877,473 | 26,305 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,448,025 | 22,573 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,049,481 | 24,418 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $3,599,352 | 22,210 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,465,892 | 23,713 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,862,683 | 24,418 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $3,396,555 | 21,670 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,229,320 | 20,734 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $3,566,293 | 21,546 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $3,326,765 | 21,463 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,841,784 | 21,748 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,540,501 | 21,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,919,096 | 89,680 | Shares | Sole | 2022-09-20 | |
| 2022-03-31 | $3,773,758 | 21,293 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,706,573 | 21,667 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,159,747 | 19,565 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $17,986,313 | 109,180 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,050,829 | 18,563 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,009,577 | 19,123 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,692,048 | 18,082 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,564,106 | 18,233 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,209,278 | 16,848 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||